# XTL Biopharmaceuticals Ltd: Form 20-F for the period ended Dec 31, 2016

- Company: [XTL Biopharmaceuticals Ltd](/companies/xtlb.md) (CIK 1023549)
- Form: 20-F
- Filed: 2017-03-30
- Accepted by EDGAR: Mar 30, 2017, 21:20 ET
- Period: 2016-12-31
- Accession: 0001144204-17-017762
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1023549/000114420417017762/v463022_20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1023549/000114420417017762/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1023549/000114420417017762/v463022_20f.htm

Filed Mar 30, 2017.
Source: SEC EDGAR, the filing index for accession 0001144204-17-017762. Last ingested by Listed: Oct 24, 2026, 15:02 ET. No prices; not investment advice.
